Preview Mode Links will not work in preview mode

Jul 31, 2024

Featuring an interview with Dr Kimberly H Allison, including the following topics:

  • Contemporary practices in pathology and reporting biomarkers of interest (0:00)
  • HER2 testing across numerous solid tumor types (2:47)
  • ER-low reporting category and pathologic interpretation (6:28)
  • PD-1/PD-L1 testing methodology and...


Jul 31, 2024

Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics:

  • Pathological assessment of HER2 and appropriate testing methodologies (0:00)
  • Effect of the DESTINY-Breast04 study on clinical practice (12:32)
  • Relevancy of HER2-ultralow expression and implications of the...


Jul 26, 2024

Featuring perspectives from Dr Dana M Chase, including the following topics:

  • Introduction: ASCO 2024 Review (0:00)
  • Ovarian Cancer (14:29)
  • HER2 as a Therapeutic Target (29:18)
  • Endometrial Cancer (38:55)
  • Cervical Cancer (51:11)

CME information and select...


Jul 25, 2024

Featuring an interview with Dr Jonathan W Goldman, including the following topics:

  • Contemporary and Future Care for Patients with Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:00)
  • Evolving First-Line Treatment for Metastatic NSCLC with an EGFR Mutation (21:05)
  • Other Emerging Strategies for...


Jul 19, 2024

Featuring perspectives from Dr Nikhil I Khushalani and Dr Jason J Luke, including the following topics:

  • Introduction (0:00)
  • Evidence-Based Treatment of Nonmetastatic and Metastatic Melanoma — Dr Luke (2:49)
  • Optimizing the Management of Nonmelanoma Skin Cancers — Dr Khushalani (36:54)

CME information and select...